Inhibition of DLL4/Notch Signaling Pathway Promotes M2 Polarization and Cell Proliferation in Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Inhibition of DLL4/Notch Signaling Pathway Promotes M2 Polarization and Cell Proliferation in Pulmonary Arterial Hypertension

Published:2024-08-26 Issue:36 Volume:9 Page:37923-37933
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Tan Guangxing¹²^ORCID,Juan Chenxia³,Mao Yan⁴,Xue Gang⁵,Fang Zhuyuan²

Affiliation:

1. Wuxi Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu 214045, China

2. Institute of Hypertension, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, China

3. Department of Nephrology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, China

4. Department of Pediatrics, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, China

5. Yangzhou Hospital of Traditional Chinese Medicine, Yangzhou, Jiangsu 225002, China

Funder

National Natural Science Foundation of China

Excellent Young Doctoral Training Program of Jiangsu Province Hospital of Chinese Medicine

Key program of Jiangsu Chinese Medicine Clinical Medicine Innovation Center for Hypertension

Jiangsu Province Hospital of Traditional Chinese Medicine

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c04307

Reference29 articles.

1. Diagnosis and Treatment of Pulmonary Arterial Hypertension

2. Pulmonary Arterial Hypertension

3. CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension

4. Ghrelin therapy improves lung and cardiovascular function in experimental emphysema

5. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension